Scout | FOR-MH-26-185: Upcoming NIMH R01 to improve clinical trial methods for psychedelics and other psychotomimetic agents

This opportunity is no longer accepting applications.

nofo FOR-MH-26-185

Upcoming NIMH R01 to improve clinical trial methods for psychedelics and other psychotomimetic agents

Summary

NIMH plans to release an R01 funding opportunity to address methodological challenges in clinical trials of psychotomimetic agents such as psilocybin, ketamine, and MDMA for mental health conditions. The aim is to pinpoint key components driving therapeutic effects and strengthen confidence in trial results, encouraging collaborations that blend psychedelic research with innovative trial desig…

The National Institute of Mental Health (NIMH) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research that addresses methodological challenges associated with clinical trials involving psychotomimetic agents (PMAs). PMAs, including classic psychedeli…

Funding Source

Agency: National Institutes of Health

Awards & funding

Total Funding: $5M

Eligibility

County governments

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Independent school districts

For profit organizations other than small businesses

Native American tribal organizations (other than Federally recognized tribal governments)

Public housing authorities/Indian housing authorities

Public and State controlled institutions of higher education

Supporting links

grants.gov

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers